National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N01BB54	EMLA	B	Prilocaine - 25mg/g, Lidocaine - 25mg/g	5%	Cream	1,763,121 L.L
D06AX01	ACIDE FUSIDIQUE BGR	G	Fusidic acid - 2%	2%	Cream	202,920 L.L
N01BB54	PRILA	G	Prilocaine - 2.5% w/w, Lidocaine - 2.5% w/w		Cream	1,057,604 L.L
D06AX01	DERMICIN	G	Fusidic acid - 20mg/g	20mg/g	Cream	175,339 L.L
D06AX01	DERMOFUCIN	G	Fusidic acid - 2%	2%	Cream	290,270 L.L
D06AX01	FUTASOLE	G	Fusidic acid - 20mg/g	2%	Cream	145,135 L.L
D06AX01	ZETA	G	Fusidic acid - 20mg/g	20mg/g	Cream	178,731 L.L
D06BA01	SILVEDERMA	G	Silver sulfadiazine - 1%	10mg/g	Cream	1,220,209 L.L
D06BA01	SILVEDERMA	G	Silver sulfadiazine - 1%	10mg/g	Cream	494,534 L.L
D06BA02	CREM-O-SULFA	G	Sulfathiazole - 5%	5%	Cream	202,216 L.L
D06BA51	IALUGEN PLUS	B	Silver sulfadiazine - 10mg/g, Sodium hyaluronate - 2mg/g		Cream	1,064,323 L.L
D06BA51	HYALO4 PLUS	G	Hyaluronic acid (sodium) - 0.2%, Silver sulfadiazine - 1%		Cream	466,313 L.L
D06BA51	SILVEZ PLUS	G	Silver sulfadiazine - , Chlorhexidine -		Cream	349,399 L.L
D06BB03	CIVAR	G	Aciclovir - 5%	5%	Cream	507,972 L.L
D06BB03	CYCLOVEX	G	Aciclovir - 50mg/g	50mg/g	Cream	267,489 L.L
D06BB10	ALDARA	B	Imiquimod - 5%	5%	Cream	6,301,277 L.L
D06BB10	GENIMOD	G	Imiquimod - 5%	5%	Cream	2,268,406 L.L
D06BB10	JEDARA	G	Imiquimod - 5%	5%	Cream	3,850,109 L.L
D06BB53	ACTI-VIR H	G	Aciclovir - 5%, Hydrocortisone acetate - 1%		Cream	833,182 L.L
D07AA02	HYDROCORTISONE ACETATE	G	Hydrocortisone acetate - 1%	1%	Cream	215,015 L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 1mg/g	0.1%	Cream	215,015 L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 1mg/g	0.1%	Cream	215,015 L.L
D07AC01	BETNOVATE	B	Betamethasone (valerate) - 0.1%	0.1% w/w	Cream	279,519 L.L
D07AC01	BETASONE	G	Betamethasone (valerate) - 1mg/g	1mg/g	Cream	120,306 L.L
D07AC01	DIPROSONE	B	Betamethasone (dipropionate) - 0.5mg/g	0.05%	Cream	291,614 L.L
D07AC04	FLUOCINOLONE ACETONIDE	G	Fluocinolone acetonide - 0.25mg/g	0.25mg/g	Cream	296,925 L.L
D07AC13	ELICA	G	Mometasone furoate - 1mg/g	0.1%	Cream	341,336 L.L
D07AC13	ELISONE	G	Mometasone furoate - 0.1%	0.1%	Cream	249,955 L.L
D07AC13	ELISONE	G	Mometasone furoate - 0.1%	0.1%	Cream	435,405 L.L
D07AC13	METASONE	G	Mometasone furoate - 0.1%	0.1%	Cream	335,321 L.L

National Cancer Registry (NCR)